Pulse Biosciences Inc. | Ownership
Companies that own Pulse Biosciences Inc.
BlackRock Fund Advisors
545,221
3.23%
95,245
0%
06/30/2018
The Vanguard Group, Inc.
237,872
1.41%
22,123
0%
06/30/2018
SSgA Funds Management, Inc.
132,692
0.79%
-2,424
0%
06/30/2018
Northern Trust Investments, Inc.
107,326
0.64%
14,231
0%
06/30/2018
Geode Capital Management LLC
70,424
0.42%
8,884
0%
06/30/2018
Wells Fargo Clearing Services LLC
59,815
0.35%
49
0%
06/30/2018
The Bank of New York Mellon Corp. (Investment Management)
57,020
0.34%
5,017
0%
06/30/2018
BlackRock Investment Management LLC
37,079
0.22%
5,705
0%
06/30/2018
Silverleafe Capital Partners LLC
33,000
0.2%
33,000
0.28%
06/30/2018
AQR Capital Management LLC
32,536
0.19%
-17,176
0%
06/30/2018
| Address |
3957 Point Eden Way
Hayward California 94545
United States
|
|
Employees
|
- |
| Website |
http://www.pulsebiosciences.com |
| Updated |
07/08/2019 |
| Pulse Biosciences, Inc. is a clinical stage electroceutical, an electrical energy based therapeutic, company pursuing commercial applications of its proprietary Nano-Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments uses a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. |
